| Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options |
117 |
| Erectile Dysfunction: AUA Guideline |
67 |
| Evaluation and Management of Testosterone Deficiency: AUA Guideline |
63 |
| Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline |
62 |
| Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019 |
56 |
| Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options |
54 |
| Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019 |
47 |
| WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation (R) vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia |
37 |
| Outcomes of Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium |
33 |
| Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer |
32 |
| Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline |
30 |
| Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens |
27 |
| Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with Ga-68-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node Pathology |
26 |
| The Impact of Positron Emission Tomography with F-18-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial |
25 |
| Robotic Assisted Radical Cystectomy vs Open Radical Cystectomy: Systematic Review and Meta-Analysis |
24 |
| Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018 |
24 |
| Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help? |
23 |
| Prostate Specific Membrane Antigen Targeted F-18-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study |
22 |
| Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation |
21 |
| Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline |
21 |
| Functional Recovery, Oncologic Outcomes and Postoperative Complications after Robot-Assisted Radical Prostatectomy: An Evidence-Based Analysis Comparing the Retzius Sparing and Standard Approaches |
21 |
| Dusting versus Basketing during Ureteroscopy-Which Technique is More Efficacious? A Prospective Multicenter Trial from the EDGE Research Consortium |
20 |
| Proteomic Signatures of Sperm Mitochondria in Varicocele: Clinical Use as Biomarkers of Varicocele Associated Infertility |
20 |
| Validation of Prostate Imaging Reporting and Data System Version 2 for the Detection of Prostate Cancer |
20 |
| The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Learning Curve Study |
19 |
| Incontinence after Prostate Treatment: AUA/SUFU Guideline |
19 |
| Transperineal Prostate Biopsies Using Local Anesthesia: Experience with 287 Patients. Prostate Cancer Detection Rate, Complications and Patient Tolerability |
19 |
| Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease |
18 |
| Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor |
18 |
| Development and Validation of Objective Performance Metrics for Robot-Assisted Radical Prostatectomy: A Pilot Study |
18 |
| Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016 |
18 |
| Evaluation of Guidelines for Surgical Management of Urolithiasis |
16 |
| Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma |
16 |
| Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study |
16 |
| Impact of Surgical Factors on Robotic Partial Nephrectomy Outcomes: Comprehensive Systematic Review and Meta-Analysis |
16 |
| Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study |
16 |
| The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate Specific Antigen and Radiographic Disease Progression in Patients with Nonmetastatic Castration Resistant Prostate Cancer |
16 |
| Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness |
16 |
| Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study |
16 |
| A Comprehensive Analysis of Cribriform Morphology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Correlated with Radical Prostatectomy Specimens |
16 |
| Is it Time to Perform Only Magnetic Resonance Imaging Targeted Cores? Our Experience with 032 Men Who Underwent Prostate Biopsy |
15 |
| Patient Reported Bladder Related Symptoms and Quality of Life after Spinal Cord Injury with Different Bladder Management Strategies |
15 |
| Objective Assessment of Robotic Surgical Technical Skill: A Systematic Review |
15 |
| Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy |
15 |
| Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer |
15 |
| The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years |
15 |
| Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study |
15 |
| Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound |
15 |
| Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy |
14 |
| Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses |
14 |
